Submitted:
08 July 2024
Posted:
09 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
2.1. Design
2.2. Participants
2.3. Setting
2.4. Procedures
2.5. Data Analysis
3. Results
4. Discussion
5. Conclusions
Authors Statements
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
References
- Khan, F.Y. Rhabdomyolysis: A Review of the Literature. Neth J Med 2009, 67, 272–283. [Google Scholar] [PubMed]
- Cervellin, G.; Comelli, I.; Lippi, G. Rhabdomyolysis: Historical Background, Clinical, Diagnostic and Therapeutic Features. Clin Chem Lab Med 2010, 48, 749–756. [Google Scholar] [CrossRef] [PubMed]
- Holt, S.G.; Moore, K.P. Pathogenesis and Treatment of Renal Dysfunction in Rhabdomyolysis. Intensive Care Med 2001, 27, 803–811. [Google Scholar] [CrossRef] [PubMed]
- Zimmerman, J.L.; Shen, M.C. Rhabdomyolysis. Chest 2013, 144, 1058–1065. [Google Scholar] [CrossRef] [PubMed]
- Gabow, P.A.; Kaehny, W.D.; Kelleher, S.P. The Spectrum of Rhabdomyolysis. Medicine (Baltimore) 1982, 61, 141–152. [Google Scholar] [CrossRef] [PubMed]
- Melli, G.; Chaudhry, V.; Cornblath, D.R. Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients. Medicine (Baltimore) 2005, 84, 377–385. [Google Scholar] [CrossRef]
- Lippi, G.; Schena, F.; Ceriotti, F. Diagnostic Biomarkers of Muscle Injury and Exertional Rhabdomyolysis. Clin Chem Lab Med 2018, 57, 175–182. [Google Scholar] [CrossRef]
- Kenney, K.; Landau, M.E.; Gonzalez, R.S.; Hundertmark, J.; O’Brien, K.; Campbell, W.W. Serum Creatine Kinase after Exercise: Drawing the Line between Physiological Response and Exertional Rhabdomyolysis. Muscle Nerve 2012, 45, 356–362. [Google Scholar] [CrossRef]
- Clarkson, P.M.; Kearns, A.K.; Rouzier, P.; Rubin, R.; Thompson, P.D. Serum Creatine Kinase Levels and Renal Function Measures in Exertional Muscle Damage. Med Sci Sports Exerc 2006, 38, 623–627. [Google Scholar] [CrossRef]
- Ehlers, G.G.; Ball, T.E.; Liston, L. Creatine Kinase Levels Are Elevated During 2-A-Day Practices in Collegiate Football Players. J Athl Train 2002, 37, 151–156. [Google Scholar]
- Denvir, M.A.; Galloway, P.J.; Meighan, A.S.; Blyth, M.; Alexander, C.; Fleming, C.; Frame, F. Changes in Skeletal and Cardiac Muscle Enzymes during the Scottish Coast to Coast Triathlon. Scott Med J 1999, 44, 49–51. [Google Scholar] [CrossRef] [PubMed]
- Oh, R.C.; Arter, J.L.; Tiglao, S.M.; Larson, S.L. Exertional Rhabdomyolysis: A Case Series of 30 Hospitalized Patients. Mil Med 2015, 180, 201–207. [Google Scholar] [CrossRef]
- O’Connor, F.G.; Brennan, F.H.; Campbell, W.; Heled, Y.; Deuster, P. Return to Physical Activity after Exertional Rhabdomyolysis. Curr Sports Med Rep 2008, 7, 328–331. [Google Scholar] [CrossRef] [PubMed]
- Shumway, J.; Irvin, A.; Shia, R.; Goodyear, C.D. Biomarkers, Creatine Kinase, and Kidney Function of Special Operation Candidates During Intense Physiological Training. Mil Med 2020, 185, e982–e987. [Google Scholar] [CrossRef] [PubMed]
- Scalco, R.S.; Snoeck, M.; Quinlivan, R.; Treves, S.; Laforét, P.; Jungbluth, H.; Voermans, N.C. Exertional Rhabdomyolysis: Physiological Response or Manifestation of an Underlying Myopathy? BMJ Open Sport Exerc Med 2016, 2, e000151. [Google Scholar] [CrossRef] [PubMed]
- Armstrong, L.E.; Maresh, C.M.; Castellani, J.W.; Bergeron, M.F.; Kenefick, R.W.; LaGasse, K.E.; Riebe, D. Urinary Indices of Hydration Status. Int J Sport Nutr 1994, 4, 265–279. [Google Scholar] [CrossRef] [PubMed]
- Moyen, N.E.; Ellis, C.L.V.; Ciccone, A.B.; Thurston, T.S.; Cochrane, K.C.; Brown, L.E.; Coburn, J.W.; Judelson, D.A. Increasing Relative Humidity Impacts Low-Intensity Exercise in the Heat. Aviat Space Environ Med 2014, 85, 112–119. [Google Scholar] [CrossRef] [PubMed]
- Pawłowska, M.; Mila-Kierzenkowska, C.; Boraczyński, T.; Boraczyński, M.; Szewczyk-Golec, K.; Sutkowy, P.; Wesołowski, R.; Budek, M.; Woźniak, A. The Influence of Ambient Temperature Changes on the Indicators of Inflammation and Oxidative Damage in Blood after Submaximal Exercise. Antioxidants (Basel) 2022, 11, 2445. [Google Scholar] [CrossRef]
- White, G.E.; Wells, G.D. Cold-Water Immersion and Other Forms of Cryotherapy: Physiological Changes Potentially Affecting Recovery from High-Intensity Exercise. ExtremPhysiol Med 2013, 2, 26. [Google Scholar] [CrossRef]
- Scheele, C.; Nielsen, S.; Pedersen, B.K. ROS and Myokines Promote Muscle Adaptation to Exercise. Trends Endocrinol Metab 2009, 20, 95–99. [Google Scholar] [CrossRef]
- Alele, F.O.; Malau-Aduli, B.S.; Malau-Aduli, A.E.O.; Crowe, M.J. Haematological, Biochemical and Hormonal Biomarkers of Heat Intolerance in Military Personnel. Biology (Basel) 2021, 10, 1068. [Google Scholar] [CrossRef] [PubMed]
- Monteiro, C.; Dias, G.; Ramos, S.; Gomes, R.; Gama, J.; Martins, F.; Mendes, R.S.; Castro, M.A. Perception of the Special Troops (Commando) Soldiers Regarding Physical Fitness, Motor Control and Psychological Skills. Applied Sciences 2022, 12, 3258. [Google Scholar] [CrossRef]
- Kimball, J.P.; Inan, O.T.; Convertino, V.A.; Cardin, S.; Sawka, M.N. Wearable Sensors and Machine Learning for Hypovolemia Problems in Occupational, Military and Sports Medicine: Physiological Basis, Hardware and Algorithms. Sensors (Basel) 2022, 22, 442. [Google Scholar] [CrossRef]
- Bustamante-Sánchez, Á.; Nikolaidis, P.T.; Clemente-Suárez, V.J. Body Composition of Female Air Force Personnel: A Comparative Study of Aircrew, Airplane, and Helicopter Pilots. Int J Environ Res Public Health 2022, 19, 8640. [Google Scholar] [CrossRef]
- Savioli, G.; Zanza, C.; Longhitano, Y.; Nardone, A.; Varesi, A.; Ceresa, I.F.; Manetti, A.C.; Volonnino, G.; Maiese, A.; La Russa, R. Heat-Related Illness in Emergency and Critical Care: Recommendations for Recognition and Management with Medico-Legal Considerations. Biomedicines 2022, 10, 2542. [Google Scholar] [CrossRef] [PubMed]
- Armed Forces Health Surveillance Branch, null Update: Exertional Rhabdomyolysis, Active Component, U.S. Army, Navy, Air Force, and Marine Corps, 2011-2015. MSMR 2016, 23, 21–24.
- Urso, C.; Brucculeri, S.; Caimi, G. Physiopathological, Epidemiological, Clinical and Therapeutic Aspects of Exercise-Associated Hyponatremia. J Clin Med 2014, 3, 1258–1275. [Google Scholar] [CrossRef]
- Mougios, V. Reference Intervals for Serum Creatine Kinase in Athletes. Br J Sports Med 2007, 41, 674–678. [Google Scholar] [CrossRef] [PubMed]
- Arbab, R.; Erb, C.; Joy, J.; Zainah, H.; Samarneh, M.M. Physiologic Response to Exercise or Rhabdomyolysis? Creatine Phosphokinase Elevation in 16 Asymptomatic Firefighters. Am J Case Rep 2022, 23, e937084. [Google Scholar] [CrossRef]
- Banfi, G.; Colombini, A.; Lombardi, G.; Lubkowska, A. Metabolic Markers in Sports Medicine. Adv Clin Chem 2012, 56, 1–54. [Google Scholar] [CrossRef]
- Brewster, L.M.; Mairuhu, G.; Sturk, A.; van Montfrans, G.A. Distribution of Creatine Kinase in the General Population: Implications for Statin Therapy. Am Heart J 2007, 154, 655–661. [Google Scholar] [CrossRef]
- Brancaccio, P.; Maffulli, N.; Limongelli, F.M. Creatine Kinase Monitoring in Sport Medicine. Br Med Bull 2007, 81–82, 209–230. [Google Scholar] [CrossRef]
- Branch, T.P.; Mayr, H.O.; Browne, J.E.; Campbell, J.C.; Stoehr, A.; Jacobs, C.A. Instrumented Examination of Anterior Cruciate Ligament Injuries: Minimizing Flaws of the Manual Clinical Examination. Arthroscopy 2010, 26, 997–1004. [Google Scholar] [CrossRef]
- Safari, S.; Yousefifard, M.; Hashemi, B.; Baratloo, A.; Forouzanfar, M.M.; Rahmati, F.; Motamedi, M.; Najafi, I. The Value of Serum Creatine Kinase in Predicting the Risk of Rhabdomyolysis-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis. Clin Exp Nephrol 2016, 20, 153–161. [Google Scholar] [CrossRef] [PubMed]
- O’Connor, F.G.; Bergeron, M.F.; Cantrell, J.; Connes, P.; Harmon, K.G.; Ivy, E.; Kark, J.; Klossner, D.; Lisman, P.; Meyers, B.K.; et al. ACSM and CHAMP Summit on Sickle Cell Trait: Mitigating Risks for Warfighters and Athletes. Med Sci Sports Exerc 2012, 44, 2045–2056. [Google Scholar] [CrossRef]
| Sex | Age | Height | Weight | BMI |
|---|---|---|---|---|
| Male (n=17) |
27.83 | 174.92 | 76.31 | 25,21 |
| ±2.96 | ±5.91 | ±7.67 | ±3.27 |
| Variable | Reference Range |
Day1 | Day2 | Day3 | Day4 | Day5 |
|---|---|---|---|---|---|---|
| CK (U/L) | (24 – 195) | 752.17±401.05 | 587.39±193.72 | 492.67±97.04† | 494.06±88.89† | 2515.22±399.07‡ |
| (92 – 7146) | (154 – 3658) | (190 – 1944) | (175 – 1448) | (610 – 6215) | ||
| BUN (mg/dL) | (10 – 50) | 36.06±1.70 | 31.56±1.21** | 34±1.22 | 44.56±2.02* | 43.44±1.73 |
| (24 – 48) | (23 – 42) | (24 – 44) | (35 – 67) | (30 – 54) | ||
| Cr (mg/dL) | (0,8 – 1,4) | 1.049±0.03 | 0.87±0.02† | 0.95±0.02‡ | 1±0.03 | 0.99±0.03 |
| (0.9 – 1.2) | (0.8 – 1) | (0.8 - 1.1) | (0.8 - 1.3) | (0.8 - 1.2) | ||
| Na (mEq/1) | (134 – 145) | 141.97±0.34 | 136.94±0.36* | 139.94±0.26* | 136.34±0.34* | 137.42±0.43* |
| (138.2 - 144.4) | (132.9 – 138.8) | (138.3 - 141.8) | (133.2 - 138.4) | (133 - 139.8) | ||
| K (mEq/1) | (3,6 – 5,5) | 4.42±0.06 | 9.18±0.25* | 4.67±0.07 | 5.88±0.10* | 4.64±0.06** |
| (3.9 - 4.9) | (7.6 – 11.7) | (4.3 - 5.1) | (5.2 - 6.7) | (4.2 - 5.2) | ||
| AST (U/L) | (0 – 38) | 50.22±13.32 | 58.22±8.38‡ | 57.39±6.41‡ | 48.89±4.81 | 112.23±13.70† |
| (23 – 265) | (24 – 177) | (24 – 120) | (24 – 90) | (40 – 266) | ||
| ALT (U/L) | (0 – 42) | 62.67±12.17 | 73.06±11.63 | 83.28±11.73† | 77.56±10.38 | 91.06±11.86† |
| (25 – 260) | (22 – 242) | (25 – 233) | (23 – 195) | (33 – 218) | ||
| Notes:*p < 0.001 (GLM Repeated Measure); **p < 0.001 (GLM Repeated Measure); †p < 0.001 (Friedman); ‡p < 0.05 (Friedman) | ||||||
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | |
|---|---|---|---|---|---|
| CK normal | 88.89% | 88.89% | 94.44% | 83.33% | 5.56% |
| (92 - 565) | (154 - 830) | (190 - 865) | (175 - 524) | (610 - 610) | |
| CK >5x | 0.00% | 5.56% | 5.56% | 16.67% | 50.00% |
| ( - ) | (1356 - 1356) | (1944 - 1944) | (1074 - 1448) | (1130 - 1814) | |
| CK >10x | 11.11% | 5.56% | 0.00% | 0.00% | 44.44% |
| (2689 - 7146) | (3658 - 3658) | ( - ) | ( - ) | (2000 - 6215) |
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BUN | Cr | BUN | Cr | BUN | Cr | BUN | Cr | BUN | Cr | ||
| CK | Day 1 | 0.297 | 0.298 | ||||||||
| (0.231) | (0.229) | ||||||||||
| Day 2 | 0.082 | 0.514# | |||||||||
| (0.747) | (0.029) | ||||||||||
| Day 3 | 0.445 | 0.339 | |||||||||
| (0.064) | (0.168) | ||||||||||
| Day 4 | 0.339 | 0.153 | |||||||||
| (0.169) | (0.543) | ||||||||||
| Day 5 | 0.504* | 0.282 | |||||||||
| (0.033) | (0.257) | ||||||||||
| Day1 | Day2 | Day3 | Day4 | Day5 | ||
|---|---|---|---|---|---|---|
| Period | Morning | 1.026 | 1.020 | 1.016 | 1.028 | 1.022 |
| (1.012-1.031) | (1.010-1.031) | (1.006-1.029) | (1.008-1.036) | (1.014-1.034) | ||
| Afternoon | 1.029 | 1.026 | 1.027 | 1.031 | 1.031 | |
| (1.022-1.035) | (1.014-1.035) | (1.018-1.032) | (1.010-1.040) | (1.018-1.037) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).